Nanomaterials for Cancer Therapy

The Series
Nanotechnologies for the Life Sciences (NtLS) is the first comprehensive source covering the convergence of materials and life sciences on the nanoscale, a wide field of research which brings together the main technology drive of the 21st century and existing, multibillion dollar markets.

Written by international experts describing the various facets of nanofabrication, the ten volumes of NtLS provide the underlying nanotechnologies for the design, creation and characterization of medical, biological and cybernetic applications. Each volume addresses in detail one particular facet of the field.

Tailor–made nanomaterials find widespread new opportunities in diagnostic and monitoring microdevices, microsurgery tools and instruments, tissue engineering, drug delivery or artificial organs, and many more. Making information available from all kinds of specialized sources throughout the disciplines involved, NtLS is essential reading for all scientists working in this field from medicine and biology through chemistry, materials science and physics to engineering.

This Volume
Volume 6 focuses on the therapy aspects of the fight against cancer. Different therapeutic strategies and technologies are surveyed and compared in which nanoparticles and nanomaterials play different roles such as the active anticancer agent, its delivery system or container, or as active material for destructive energy absorption in the cancer tissue. Controlled release and highly targeted delivery are focal topics throughout the book.
Diagnostic and diagnostic–therapeutic aspects are covered in volume 7.

Chapter 1: Conventional chemotherapeutic drug nanoparticles for cancer treatment by L. Serpe et al.

Chapter 2: Nanoparticles for photodynamic therapy of cancer by M.Z. Labouebe et al.

Chapter 3: Nanoparticles for Neutron Capture Therapy of Cancer by H. Ichikawa et al.

Chapter 4: Nano vehicles and high molecular weight delivery agents for Boron Neutron capture therapy by Gong Wu et al.

Chapter 5: Local cancer therapy with magnetic drug targeting using magnetic nanoparticles by C. Alexiou et al.

Chapter 6: Nanomaterials for controlled release of anticancer agents by D.K. Kim et al.

Chapter 7: Critical analysis of cancer therapy using nanomaterials by L. Juillerat et al.

Chapter 8: Nanoparticles for thermotherapy by A. Jordan

Chapter 9: Ferromagnetic filled carbon nanotubes as novel and potential containers for anticancer treatment strategies by I. Mönch et al.

Chapter 10: Lyposomes, dendrimers and other nanoparticles for targeted delivery of anticancer agents – a comparative study by Y. Zhang et al.

Chapter 11: Colloidal systems for the delivery of anticancer agents in breast cancers and multiple Myeloma by S. Maillard et al.

Challa Kumar is currently the Group Leader of Nanofabrication at the Center for Advanced Microstructures and Devices (CAMD), Baton Rouge, USA. His research interests are in developing novel synthetic methods for functional nanomaterials and innovative therapeutic, diagnostic and sensory tools based on nanotechnology. He has eight years of industrial R&D experience working for Imperial Chemical Industries and United Breweries prior to joining CAMD. He is the founding Editor–in–Chief of the Journal of Biomedical Nanotechnology, an international peer reviewed journal published by American Scientific Publishers, and the series editor for the ten–volume book series Nanotechnologies for the Life Sciences (NtLS) published by Wiley–VCH. He worked at the Max Planck Institute for Biochemistry in Munich, Germany, as a post doctoral fellow and at the Max Planck Institute for Carbon Research in Mülheim, Germany, as an invited scientist. He obtained his Ph.D. degree in synthetic organic chemistry from Sri Sathya Sai Institute of Higher Learning, Prashanti Nilayam, India.